In this context, An et al. developed GPC3-targeted immunoPET tracers based on a novel single-domain antibody (“G2”), labeled with both 68Ga and 18F, for the detection of hepatocellular carcinoma in preclinical mouse models [29]. The gene discussed is GPC3; the disease is hepatocellular carcinoma.